Diabetes and hypertension
- PMID: 2076856
- DOI: 10.1055/s-2007-1004983
Diabetes and hypertension
Abstract
Diabetes mellitus and hypertension constitute two powerful independent risk factors for cardiovascular, renal and atherosclerotic disease. The frequent occurrence of the two diseases in the same individual doubles the risk of cardiovascular death, as well as substantially increasing the frequency of transient ischemic attacks, strokes, peripheral vascular disease with lower extremity amputations, as well as end-stage renal disease and blindness. Although hypertension usually occurs in IDDM in association with renal disease, in NIDDM the evolution of hypertension appears to be multifactorial and independent of renal disease. Obesity appears to be dissociable from hypertension and NIDDM with a common link between obesity, hypertension and NIDDM appearing to be hyperinsulinism and insulin resistance. It has been suggested that hyperinsulinism and insulin resistance may lead to hypertension through altered intracellular calcium metabolism, enhanced renal sodium reabsorption, or through an effect of insulin upon lipid and/or catecholamine metabolism. Further, insulin itself may have a direct effect upon the atherosclerotic process in the hypertensive diabetic patient. These considerations have been taken into account in the structuring of antihypertensive therapy in Type I and Type II Diabetes Mellitus.
Similar articles
-
Diabetes and hypertension: a review.Prim Care. 1991 Sep;18(3):509-24. Prim Care. 1991. PMID: 1658839 Review.
-
[Hypertension in patients with diabetes mellitus--selected pathogenetic and therapeutic aspects].Przegl Lek. 2001;58(3):124-6. Przegl Lek. 2001. PMID: 11475857 Review. Polish.
-
[Insulin resistance and arterial hypertension].Herz. 1995 Feb;20(1):16-32. Herz. 1995. PMID: 7713473 Review. German.
-
Relationship between hypertension and subtle and overt abnormalities of carbohydrate metabolism.J Am Soc Nephrol. 1990 Sep;1(3 Suppl 1):S39-47. J Am Soc Nephrol. 1990. PMID: 16989076 Review.
-
New drugs and clinical trials in diabetes and hypertension.Exp Clin Endocrinol Diabetes. 1997;105 Suppl 2:64-9. doi: 10.1055/s-0029-1211801. Exp Clin Endocrinol Diabetes. 1997. PMID: 9288549 Review.
Cited by
-
Mechanisms mediating insulin-induced hypotension in rats. A role for nitric oxide and autonomic mediators.Acta Diabetol. 1996 Dec;33(4):263-8. doi: 10.1007/BF00571561. Acta Diabetol. 1996. PMID: 9033965
-
Investigation of multimorbidity patterns and association rules in patients with type 2 diabetes mellitus using association rules mining algorithm.Sci Rep. 2025 Jul 16;15(1):25741. doi: 10.1038/s41598-025-09926-8. Sci Rep. 2025. PMID: 40670483 Free PMC article.
-
Blood Pressure and Late Pregnancy Circulating miRNAs in the MADRES Study.J Am Heart Assoc. 2025 Jun 17;14(12):e040416. doi: 10.1161/JAHA.124.040416. Epub 2025 Jun 11. J Am Heart Assoc. 2025. PMID: 40497511 Free PMC article.
-
Predictive model for persistent hypertension after surgical intervention of primary aldosteronism.Sci Rep. 2023 Jul 22;13(1):11868. doi: 10.1038/s41598-023-39028-2. Sci Rep. 2023. PMID: 37481689 Free PMC article.
-
Consideration of inequalities in effectiveness trials of mHealth applications - a systematic assessment of studies from an umbrella review.Int J Equity Health. 2024 Sep 11;23(1):181. doi: 10.1186/s12939-024-02267-4. Int J Equity Health. 2024. PMID: 39261871 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical